MO1 - COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERALIZABLE REAL-WORLD DATA: INSIGHTS INTO EFFECTS, COSTS, AND COST-EFFECTIVENESS OF NOVEL TREATMENT SEQUENCES IN PATIENTS WITH MULTIPLE MYELOMA
Blommestein, H., van Beurden-Tan, C., de Groot, S., Blijlevens, N., Sonneveld, P., Groot CA, Uyl-de, Zweegman, S., Franken, M.G.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.061
Date:
October, 2018
File:
PDF, 651 KB
2018